We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Research Report

Arylamine N-acetyltransferase gene polymorphisms: markers for atopic asthma, serum IgE and blood eosinophil counts

    Jyotsna Batra

    Institute of Genomics and Integrative Biology, Mall Road, Delhi-110007, India.

    Search for more papers by this author

    Email the corresponding author at bghosh@igib.res.in

    ,
    Surendra K Sharma

    All India Institute of Medical Sciences, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Delhi-110029, India.

    Search for more papers by this author

    Email the corresponding author at surensk@hotmail.com

    &
    Balaram Ghosh

    † Author for correspondence

    Institute of Genomics and Integrative Biology, Mall Road, Delhi-110007, India.

    Search for more papers by this author

    Email the corresponding author at bghosh@igib.res.in

    Published Online:3 Aug 2006https://doi.org/10.2217/14622416.7.5.673

    Abstract

    Introduction: Polymorphisms in N-acetyltransferase 2 (NAT2), present on chromosome 8p22, are responsible for the N-acetylation variants, which segregate human populations into rapid, intermediate and slow acetylators and influence the susceptibility towards atopic disorders. We have undertaken a study of the North Indian population to screen for various NAT2 polymorphisms and to investigate their association with atopic asthma and related phenotypes. Methods: First, to establish linkage of the 8p22 region with asthma, 158 families were recruited from North India. Next, a total of 219 unrelated atopic asthmatics and 210 unrelated healthy controls were recruited for case–control disease association studies. Results: A suggestive linkage was observed with microsatellite marker D8S549, 2.6 MB upstream of NAT2. By sequencing the DNA of 40 individuals, the T111C, G191A, A434C and C759T single nucleotide polymorphisms (SNPs) in NAT2 were found to be nonpolymorphic in our population and a pattern of strong linkage disequilibrium was observed among the T341C, C481T and A803G polymorphisms. Thus, a total of 429 individuals were genotyped for the C481T and unlinked C282T polymorphisms. The C481T polymorphism was found to be significantly associated with asthma in our case–control studies at the genotype level (Armitage p = 0.00027). C481T also showed a marginal association with serum total IgE (TsIgE) (p = 0.022). Furthermore, percent blood eosinophil counts were found to be significantly higher in patients carrying the 481T allele (p = 0.0037). Significant association was also detected with respect to the C282T polymorphism and TsIgE (p = 0.008). Moreover, C_T was found to be an important risk (p = 0.001), while C_C was a major protective haplotype (p = 0.0005). The associations remained significant after Bonferroni correction for multiple testing. Conclusion: In summary, the genetic variants of the NAT2 gene do not seem to affect asthma alone, but act as modulators of asthma-related traits, such as serum IgE and blood eosinophil counts, and therefore could serve as genetic markers.

    Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.

    Bibliography

    • 1  Frieri M: Asthma concepts in the new millennium: update in asthma pathophysiology. Allergy Asthma Proc.26(2),83–88 (2005).
      MedlineGoogle Scholar
    • 2  Maddox L, Schwartz DA: The pathophysiology of asthma. Annu. Rev. Med.53,477–498 (2002).
      Medline CASGoogle Scholar
    • 3  Sengler C, Lau S, Wahn U, Nickel R: Interactions between genes and environmental factors in asthma and atopy: new developments. Respir. Res.3,7–22 (2002).
      MedlineGoogle Scholar
    • 4  Kabesch M: Gene by environment interactions and the development of asthma and allergy. Toxicol. Lett.162(1),43–48 (2006).
      Medline CASGoogle Scholar
    • 5  McCunney RJ: Asthma, genes, and air pollution. J. Occup. Environ. Med.47(12),1285–1291 (2005).
      Medline CASGoogle Scholar
    • 6  Sharma S, Mann D, Singh TP, Ghosh B: Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population. J. Hum. Genet.50(12),611–617 (2005).
      Medline CASGoogle Scholar
    • 7  Fryer AA, Bianco A, Hepple M, Jones PW, Strange RC, Spiteri MA: Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med.161,1437–1442 (2000).
      Medline CASGoogle Scholar
    • 8  Mapp CE, Fryer AA, De Marzo N et al.: Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol.109,867–872 (2002).
      Medline CASGoogle Scholar
    • 9  Vavilin VA, Makarova SI, Liakhovich VV, Gavalov SM: Polymorphic genes of xenobiotic-metabolizing enzymes associated with bronchial asthma in genetically predisposed children. Genetika38(4),539–545 (2002).
      Medline CASGoogle Scholar
    • 10  Wikman H, Piirila P, Rosenberg C et al.: N-acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk. Pharmacogenetics12,227–233 (2002).
      Medline CASGoogle Scholar
    • 11  Sorensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O: Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett.221(2),185–190 (2005).
      Medline CASGoogle Scholar
    • 12  Hein DW, Doll MA, Rustan TD et al.: Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis14,1633–1638 (1993).
      Medline CASGoogle Scholar
    • 13  Flammang TJ, Kadlubar FF: Acetyl coenzyme A dependent metabolic activation of N-hydroxy-3, 2-dimethyl- 4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissues and species differences, other acyl donors and arylhydroxamic acid dependent acetyltransferases. Carcinogenesis7,926–929 (1986).
      Google Scholar
    • 14  Mattano SS, Land S, King CM, Weber WW: Purification and biochemical characterization of hepatic N-acetyltransferase from rapid and acetylator mice: identity with arylhydroxamic acid N, O-acetyltransferase and N hydroxylamine O-acetyltransferase. Mol. Pharmacol.35,599–609 (1989).
      Medline CASGoogle Scholar
    • 15  Fretland AJ, Doll MA, Gray K, Feng Y, Hein DW: Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens. Toxicol. Appl. Pharmacol.142(2),360–366 (1997).
      Medline CASGoogle Scholar
    • 16  Hein DW, Doll MA, Fretland AJ et al.: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomark. Prev.9,29–42 (2000).
      Medline CASGoogle Scholar
    • 17  Franke S, Klawitz I, Schnakenberg E et al.: Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem. Biophys. Res. Commun.199,52–55 (1994).
      Medline CASGoogle Scholar
    • 18  Hickman D, Risch A, Buckle V et al.: Chromosomal localisation of human genes for arylamine N-acetyltransferase. Biochem. J.297,441–445 (1994).
      Medline CASGoogle Scholar
    • 19  Hein DW, Grant DM and Sim E: Update on consensus arylamine N-acetyltransferase gene nomenclature. Pharmacogenetics10,1–2 (2000).
      Google Scholar
    • 20  Pawlik A, Ostanek L, Brzosko I et al.: Increased genotype frequency of N-acetyltransferase 2 slow acetylation patients with rheumatoid arthritis. Clin. Pharmacol. Ther.72,319–325 (2002).
      Medline CASGoogle Scholar
    • 21  Yalin S, Hatungil R, Tamer L et al.: N-acetyltransferase 2 polymorphism in patients with diabetes mellitus. Cell Biochem. Funct.[Epub ahead of print] (2006).
      Google Scholar
    • 22  Hein DW: N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol. Lett.112–113, 349–356 (2000).
      Google Scholar
    • 23  Debiec-Rychter M, Land SJ, King CM: Histological localization of acetyltransferases in human tissue. Cancer Lett.143(2),99–102 (1999).
      Medline CASGoogle Scholar
    • 24  Mace K, Bowman ED, Vautravers P, Shields PG, Harris CC, Pfeifer AM: Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer34(6),914–920 (1998).
      Medline CASGoogle Scholar
    • 25  Makarova SI, Vavilin VA, Lyakhovich VV, Gavalov SM: Allele NAT2*5 determines resistance to bronchial asthma in children. Bull. Exp. Biol. Med.129(6),575–577 (2000).
      Medline CASGoogle Scholar
    • 26  Nacak M, Aynacioglu AS, Filiz A et al.: Frequencies of arylamine N-acetyltransferase2 (NAT2) mutations in patients with bronchial asthma. Br. J. Clin. Pharmacol.54,671–674 (2002).• This study shows an association between acetylation polymorphism and susceptibility to extrinsic asthma, suggesting a minor role of the NAT2 polymorphism in the development of atopic asthma.
      Medline CASGoogle Scholar
    • 27  Luszawska-Kutrzeba T: NAT2* genotype in children with bronchial asthma and other atopic diseases. Ann. Acad. Med. Stetin.45,109–121 (1999).
      Medline CASGoogle Scholar
    • 28  Gawronska-Szklarz B, Luszawska-Kutrzeba T, Czaja-Bulsa G, Kurzawski G: Relationship between acetylation polymorphism and risk of atopic diseases. Clin. Pharmacol. Ther.65(5),562–569 (1999).
      Medline CASGoogle Scholar
    • 29  Zielinska E, Niewirowski W, Bodalski J, Stanczyk A, Bolanowski W, Rebowski G: Arylamine N-acetyltransferase (NAT2) gene mutations in children with allergic diseases. Clin. Pharmacol. Ther.62,635–642 (1997).
      Medline CASGoogle Scholar
    • 30  Chatterjee R, Batra J, Kumar A et al.: Interleukin-10 promoter polymorphisms and atopic asthma in North Indians. Clin. Exp. Allergy35(7),914–919 (2005).• Demonstrated the association of three IL10 promoter polymorphisms with atopic asthma at the genotype as well as at the haplotype levels in the North Indian population.
      Medline CASGoogle Scholar
    • 31  Doll MA, Fretland AJ, Deitz AC, Hein DW: Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Anal. Biochem.231(2),413–420 (1995).
      Medline CASGoogle Scholar
    • 32  Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics21(2),263–265 (2005).
      Medline CASGoogle Scholar
    • 33  Sasieni PD: From genotypes to genes: doubling the sample size. Biometrics53(4),1253–1261 (1997).
      Medline CASGoogle Scholar
    • 34  Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet.68,978–989 (2001).
      Medline CASGoogle Scholar
    • 35  Sham PC, Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet.59,97–105 (1995).
      Medline CASGoogle Scholar
    • 36  Boutin-Forzano S, Hammou Y, Gouitaa M, Charpin D: Air pollution and atopy. Allerg. Immunol.37(1),11–16 (2005).
      Medline CASGoogle Scholar
    • 37  Nacak M, Erbagci Z, Aynacioglu AS: Human arylamine N-acetyltransferase 2 polymorphism and susceptibility to allergic contact dermatitis. Int. J. Dermatol.45(3),323–326 (2006).
      Medline CASGoogle Scholar
    • 38  Seiler N: Catabolism of polyamines. Amino Acids26(3),217–233 (2004).
      Medline CASGoogle Scholar
    • 39  Fajardo I, Urdiales JL, Paz JC, Chavarria T, Sanchez-Jimenez F, Medina MA: Histamine prevents polyamine accumulation in mouse C57.1 mast cell cultures. Eur. J. Biochem.268(3),768–773 (2001).
      Medline CASGoogle Scholar
    • 40  Endo Y: Elevation of histamine levels in rat and mouse tissues by the deacetylation of administered N-acetylhistamine. Eur. J. Pharmacol.60(4),299–305 (1979).
      Medline CASGoogle Scholar
    • 41  Scheuch E, Walter R, Hadasova E, Amon I, Siegmund W: Influence of H2-receptor and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism. Pharmazie51(7),493–497 (1996).
      Medline CASGoogle Scholar
    • 42  Sabbagh A, Darlu P: SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype. Genet. Med.8(2),76–85 (2006).
      Medline CASGoogle Scholar
    • 43  Leff MA, Fretland AJ, Doll MA, Hein DW: Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype. J. Biol. Chem.274(49),34519–34522 (1999).• Demonstrated the mechanism of difference in the acetylator phenotypes due to different genetic variants in humans by assessing the mRNA and protein expression levels and protein stability.
      Medline CASGoogle Scholar
    • 44  Anitha A, Banerjee M. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India. Int. J. Mol. Med.11(1),125–131 (2003).
      Medline CASGoogle Scholar
    • 45  Bouzigon E, Dizier MH, Krahenbuhl C et al.: Clustering patterns of LOD scores for asthma-related phenotypes revealed by a genome-wide screen in 295 French EGEA families. Hum. Mol. Genet.13(24),3103–3113 (2004).
      Medline CASGoogle Scholar
    • 101  TDT/S-TDT program from the Spielman laboratory. http://genomics.med.upenn.edu/spielman/TDT.htm
      Google Scholar
    • 102  FINETTI program webpage. http://ihg.gsf.de/cgi-bin/hw/hwa1.pl
      Google Scholar
    • 103  The Laboratory of Statistical Genetics at Rockefeller University website. http://linkage.rockefeller.edu/
      Google Scholar